Physician profile
John S Thabes
NPI 1164447231
$1,938.95
in general payments reported to CMS, 2019-2025
28 companies · $697 in 2025
The $697 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $30.53 · 2021: $141 · 2022: $253 · 2023: $176 · 2024: $326 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $382.92 | 2019-2025 | Smartvest |
| Insmed, INC. | $292.51 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.26 | 2019-2025 | Ofev |
| Pulmonx Corporation | $159.19 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Ethicon INC. | $140.61 | 2025 | Monarch Platform |
| Glaxosmithkline, LLC. | $87.28 | 2019-2025 | Nucala |
| Sunovion Pharmaceuticals INC. | $68.83 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $65.93 | 2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $61.91 | 2019-2022 | |
| Stryker Corporation | $46.63 | 2025 | Flowtriever |
| Genentech USA, INC. | $43.66 | 2019 | |
| Amgen INC. | $37.97 | 2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $36.00 | 2023-2024 | Acthar |
| Regeneron Healthcare Solutions, INC. | $35.60 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $30.71 | 2022-2025 | Airsupra |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $24.66 | 2024 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $24.64 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.23 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $24.06 | 2024 | Opsumit |
| Inspire Medical Systems, INC. | $23.71 | 2024 | Inspire |
| Genzyme Corporation | $20.20 | 2024 | |
| Baxter Healthcare | $20.11 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Resmed Corp | $18.68 | 2022 | |
| Mylan Specialty L.P. | $17.09 | 2020 | |
| Fisher & Paykel Healthcare INC | $16.10 | 2021 | |
| Ucb, INC. | $14.38 | 2022 | |
| Tactile Systems Technology INC | $12.92 | 2023 | Flexitouch Plus, Entre Plus |
| United Therapeutics Corporation | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thabes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.